Suppr超能文献

伊维菌素经口服给予犬类后的生物利用度。

Bioavailability of ivermectin administered orally to dogs.

作者信息

Daurio C P, Cheung E N, Jeffcoat A R, Skelly B J

机构信息

Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065.

出版信息

Vet Res Commun. 1992;16(2):125-30. doi: 10.1007/BF01839009.

Abstract

The bioavailability of three formulations of ivermectin was determined following oral administration to dogs. The average peak plasma level (Cmax) of ivermectin administered in the standard tablet formulation at 6 and 100 micrograms/kg of body weight was 2.97 and 44.31 ng/g, respectively. This suggest dose-dependent pharmacokinetics. Cmax and total ivermectin bioavailability, as assessed from the area under the plasma curve (AUC), were similar between two tablet formulations of ivermectin administered at 100 micrograms/kg. Furthermore, Cmax was similar following administration of radiolabelled ivermectin at 6 micrograms/kg in either a beef-based chewable formulation or in the standard tablet formulation.

摘要

给犬口服三种伊维菌素制剂后测定其生物利用度。以6微克/千克和100微克/千克体重给予标准片剂制剂的伊维菌素,其平均血浆峰值水平(Cmax)分别为2.97纳克/克和44.31纳克/克。这表明存在剂量依赖性药代动力学。从血浆曲线下面积(AUC)评估,以100微克/千克给予的两种伊维菌素片剂制剂的Cmax和伊维菌素总生物利用度相似。此外,以6微克/千克给予放射性标记的伊维菌素,无论是牛肉味咀嚼片制剂还是标准片剂制剂,给药后的Cmax相似。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验